A mitochondria-localized iridium(III) photosensitizer for two-photon photodynamic immunotherapy against melanoma

Lili Wang,Johannes Karges,Fangmian Wei,Lina Xie,Zhuoli Chen,Gilles Gasser,Liangnian Ji,Hui Chao
DOI: https://doi.org/10.1039/d2sc06675k
IF: 8.4
2023-01-13
Chemical Science
Abstract:Conventional photodynamic therapy mainly causes a therapeutic effect on the primary tumor through the localized generation of reactive oxygen species, while metastatic tumors remain poorly affected. Complementary immunotherapy is effective in eliminating small, non-localized tumors distributed across multiple organs. Here, we report that Ir(III) complex Ir-pbt-Bpa is a highly potent ICD-inducing photosensitizer for two-photon photodynamic immunotherapy against melanoma. Ir-pbt-Bpa can produce singlet oxygen and superoxide anion radicals upon light irradiation, causing cell death by a combination of ferroptosis and immunogenic cell death. In a mouse model with two physically separated melanoma tumors, although only one of the primary tumors was irradiated, a strong tumor reduction of both tumors was observed. Upon irradiation, Ir-pbt-Bpa not only induced the immune response of CD8+ T cells and the depletion of regulatory T cells, but also caused an increase in the number of the effector memory T cells to achieve long-term anti-tumor immunity.
What problem does this paper attempt to address?